Aptamer-based approaches in leukemia: a paradigm shift in targeted therapy

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Aptamers are synthetic single-stranded DNA or RNA molecules.
• They function as chemical antibodies with high specificity.
• Aptamers are emerging as key tools in cancer diagnosis and treatment, especially for leukemia.

Purpose of the Study:

• To review recent advancements in aptamer-based technologies for leukemia.
• To highlight the potential of aptamers in personalized medicine and oncology.
• To discuss challenges and obstacles in the clinical application of aptamers.

Main Methods:

• Review of recent scientific literature on aptamer applications in leukemia.
• Analysis of aptamer-based diagnostic and therapeutic strategies.
• Exploration of aptamer targeting of biomarkers and drug delivery enhancement.

Main Results:

• Aptamers demonstrate high cost-effectiveness, sensitivity, and precision.
• They enable specific targeting of aberrant biomarkers and modulation of signaling pathways.
• Aptamers enhance drug delivery efficacy, optimizing therapeutic outcomes.
• Potential to refine prognostic models and improve minimal residual disease monitoring.

Conclusions:

• Aptamers offer significant potential for transforming leukemia diagnosis and treatment.
• They are pivotal in advancing personalized medicine approaches in oncology.
• Further research is needed to overcome challenges for full clinical integration.